Ozempic Maker Novo Nordisk Sinks On Disappointing Earnings

Novo Nordisk’s growth has slowed in recent weeks as the company struggles to produce enough semaglutide to meet stellar demand for Wegovy and Ozempic.

Aug 7, 2024 - 12:00
 0  2
Ozempic Maker Novo Nordisk Sinks On Disappointing Earnings
Novo Nordisk’s growth has slowed in recent weeks as the company struggles to produce enough semaglutide to meet stellar demand for Wegovy and Ozempic.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow